|
Bieżący numer
Archiwum
Filmy
Artykuły w druku
O czasopiśmie
Suplementy
Rada naukowa
Recenzenci
Bazy indeksacyjne
Prenumerata
Kontakt
Zasady publikacji prac
Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
|
4/2007
vol. 109 streszczenie artykułu:
Opis przypadku
Monoclonal anti-TNFα antibody (infliximab) in the treatment of patient with thyroid associated ophthalmopathy
Jan Komorowski
1
,
Joanna Jankiewicz-Wika
1
,
Agnieszka Siejka
1
,
Hanna Ławnicka
2
,
Anna Kłysik
3
,
Roman Goś
3
,
Agata Majos
4
,
Ludomir Stefańczyk
4
,
Henryk Stępień
2
1.
Department of Clinical Endocrinology , Medical University of Łódź, Poland. Head: Professor Jan Komorowski, MD, PhD
2.
Department of Clinical Immunoendocrinology , Medical University of Łódź, Poland. Head: Professor Henryk Stępień, MD, PhD
3.
Department of Clinical Ophthalmology , Medical University of Łódź, Poland. Head: Professor Roman Goś, MD, PhD
4.
Department of Radiology, Medical University of Łódź, Poland. Head: Professor Ludomir Stefańczyk, MD, PhD
Klinika Oczna 2007, 109 (4): 457-460
Data publikacji online: 2007/12/20
Pełna treść artykułu
Pobierz cytowanie
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
TNFα (tumor necrosis factor alpha) plays a central role in the development of thyroid associated ophthalmopathy (TAO). We describe and document by ophthalmic (CAS and NO SPECS scales) and radiological (MRI) evaluation a positive effect of anti-TNFα antibody (infliximab) administration on active TAO in a 58 years old woman with Graves’ disease. The single dose of infliximab administration resulted in a dramatic reduction of inflammation studies and improvement of visual function as measured by MRI and CAS and NO SPECS scales, without noticeable short-term side effects. A randomized prospective study is needed to determine whether infliximab proves to be sufficiently effective in reducing the inflammatory symptoms of TAO, and whether it can be administered safely for a prolonged period without side effects. słowa kluczowe:
TNFα, anty-TNFα, oftalmopatia Graves’a |
|
ENGLISH
